TGFB1 and diabetic kidney disease: Two models were used in this study for determining renal fibrosis: an in vivo model in which STZ was used for inducing diabetic nephropathy in rats and an in vitro model where renal fibrosis was determined by treating fibroblasts with recombinant TGF-β1 (rhTGF-β1).